Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome.

Genet Med 2011 Feb;13(2):95-101

Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Purpose: This study evaluated the safety and effectiveness of long-term enzyme replacement therapy with idursulfase (recombinant human iduronate-2-sulfatase) in patients with Hunter syndrome.

Methods: All 94 patients who completed a 53-week double-blinded study of idursulfase enrolled in this open-labeled extension study and received intravenous idursulfase at a dose of 0.5 mg/kg weekly for 2 years, and clinical outcomes and safety were assessed.

Results: No change in percent predicted forced vital capacity was seen, but absolute forced vital capacity demonstrated sustained improvement and was increased 25.1% at the end of the study. Statistically significant increases in 6-minute walking test distance were observed at most time points. Mean liver and spleen volumes remained reduced throughout the 2-year extension study. Mean joint range of motion improved for the shoulder and remained stable in other joints. Both the parent- and child-assessed Child Health Assessment Questionnaire Disability Index Score demonstrated significant improvement. Infusion-related adverse events occurred in 53% of patients and peaked at Month 3 of treatment and declined thereafter. Neutralizing IgG antibodies were detected in 23% of patients and seemed to attenuate the improvement in pulmonary function.

Conclusions: Weekly infusions of idursulfase result in sustained clinical improvement during 3 years of treatment.

Download full-text PDF

Source
http://dx.doi.org/10.1097/GIM.0b013e3181fea459DOI Listing
February 2011
49 Reads

Publication Analysis

Top Keywords

extension study
12
open-labeled extension
8
study idursulfase
8
vital capacity
8
forced vital
8
study
6
idursulfase
5
reduced 2-year
4
2-year extension
4
remained reduced
4
study joint
4
liver spleen
4
joint range
4
spleen volumes
4
volumes remained
4
remained stable
4
stable joints
4
joints parent-
4
parent- child-assessed
4
points liver
4

Similar Publications